CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman’s Syndrome
Asherman’s syndrome is an acquired condition of uterine fibrosis and adhesions in response to injury that adversely affects fertility and pregnancy. We have previously demonstrated that bone marrow-derived mesenchymal stem cells (BMDSCs) contribute to uterine repair after injury and that stem cells...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2017-03-01
|
| Series: | Molecular Therapy: Methods & Clinical Development |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050117300050 |
| _version_ | 1811237472383795200 |
|---|---|
| author | Gulcin Sahin Ersoy Masoumeh Majidi Zolbin Emine Cosar Irene Moridi Ramanaiah Mamillapalli Hugh S. Taylor |
| author_facet | Gulcin Sahin Ersoy Masoumeh Majidi Zolbin Emine Cosar Irene Moridi Ramanaiah Mamillapalli Hugh S. Taylor |
| author_sort | Gulcin Sahin Ersoy |
| collection | DOAJ |
| description | Asherman’s syndrome is an acquired condition of uterine fibrosis and adhesions in response to injury that adversely affects fertility and pregnancy. We have previously demonstrated that bone marrow-derived mesenchymal stem cells (BMDSCs) contribute to uterine repair after injury and that stem cells supplementation improves fertility. Here, we demonstrate that CXCL12 is the chemokine that mediates stem cell engraftment and functional improvement using a murine model of Asherman’s syndrome. After uterine injury, we demonstrate that CXCL12 augmentation increased BMDSC engraftment and that the CXCL12 receptor (CXCR4) antagonist, ADM3100, blocked stem cell recruitment. CXCL12 reduced, whereas ADM3100 increased fibrosis. CXCL12 treatment led to improved fertility and litter size, whereas ADM3100 treatment reduced fertility and litter size. ADM3100 prevented optimal spontaneous uterine repair mediated by endogenous CXCL12 production, reducing pregnancies after injury in the absence of supplemental CXCL12 administration; however, ADM3100 treatment could be partially rescued by CXCL12 augmentation. CXCL12 or other CXCR4 receptor agonists may be useful in the treatment of infertility or adverse pregnancy outcomes in Asherman’s syndrome and other related uterine disorders. |
| first_indexed | 2024-04-12T12:24:00Z |
| format | Article |
| id | doaj.art-2ed5f278880744bd82f5d56cb3bf7462 |
| institution | Directory Open Access Journal |
| issn | 2329-0501 |
| language | English |
| last_indexed | 2024-04-12T12:24:00Z |
| publishDate | 2017-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Molecular Therapy: Methods & Clinical Development |
| spelling | doaj.art-2ed5f278880744bd82f5d56cb3bf74622022-12-22T03:33:13ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012017-03-014C16917710.1016/j.omtm.2017.01.001CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman’s SyndromeGulcin Sahin Ersoy0Masoumeh Majidi Zolbin1Emine Cosar2Irene Moridi3Ramanaiah Mamillapalli4Hugh S. Taylor5Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06520, USADepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06520, USADepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06520, USADepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06520, USADepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06520, USADepartment of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT 06520, USAAsherman’s syndrome is an acquired condition of uterine fibrosis and adhesions in response to injury that adversely affects fertility and pregnancy. We have previously demonstrated that bone marrow-derived mesenchymal stem cells (BMDSCs) contribute to uterine repair after injury and that stem cells supplementation improves fertility. Here, we demonstrate that CXCL12 is the chemokine that mediates stem cell engraftment and functional improvement using a murine model of Asherman’s syndrome. After uterine injury, we demonstrate that CXCL12 augmentation increased BMDSC engraftment and that the CXCL12 receptor (CXCR4) antagonist, ADM3100, blocked stem cell recruitment. CXCL12 reduced, whereas ADM3100 increased fibrosis. CXCL12 treatment led to improved fertility and litter size, whereas ADM3100 treatment reduced fertility and litter size. ADM3100 prevented optimal spontaneous uterine repair mediated by endogenous CXCL12 production, reducing pregnancies after injury in the absence of supplemental CXCL12 administration; however, ADM3100 treatment could be partially rescued by CXCL12 augmentation. CXCL12 or other CXCR4 receptor agonists may be useful in the treatment of infertility or adverse pregnancy outcomes in Asherman’s syndrome and other related uterine disorders.http://www.sciencedirect.com/science/article/pii/S2329050117300050stem cellsAsherman’s syndromeuterusfertilityCXCL12AMD3100CXCR4intrauterine adhesionscell therapy |
| spellingShingle | Gulcin Sahin Ersoy Masoumeh Majidi Zolbin Emine Cosar Irene Moridi Ramanaiah Mamillapalli Hugh S. Taylor CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman’s Syndrome Molecular Therapy: Methods & Clinical Development stem cells Asherman’s syndrome uterus fertility CXCL12 AMD3100 CXCR4 intrauterine adhesions cell therapy |
| title | CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman’s Syndrome |
| title_full | CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman’s Syndrome |
| title_fullStr | CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman’s Syndrome |
| title_full_unstemmed | CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman’s Syndrome |
| title_short | CXCL12 Promotes Stem Cell Recruitment and Uterine Repair after Injury in Asherman’s Syndrome |
| title_sort | cxcl12 promotes stem cell recruitment and uterine repair after injury in asherman s syndrome |
| topic | stem cells Asherman’s syndrome uterus fertility CXCL12 AMD3100 CXCR4 intrauterine adhesions cell therapy |
| url | http://www.sciencedirect.com/science/article/pii/S2329050117300050 |
| work_keys_str_mv | AT gulcinsahinersoy cxcl12promotesstemcellrecruitmentanduterinerepairafterinjuryinashermanssyndrome AT masoumehmajidizolbin cxcl12promotesstemcellrecruitmentanduterinerepairafterinjuryinashermanssyndrome AT eminecosar cxcl12promotesstemcellrecruitmentanduterinerepairafterinjuryinashermanssyndrome AT irenemoridi cxcl12promotesstemcellrecruitmentanduterinerepairafterinjuryinashermanssyndrome AT ramanaiahmamillapalli cxcl12promotesstemcellrecruitmentanduterinerepairafterinjuryinashermanssyndrome AT hughstaylor cxcl12promotesstemcellrecruitmentanduterinerepairafterinjuryinashermanssyndrome |